Articles Vol. 65 No. 6 30/10/2024

22. DIRECT MEDICAL COSTS FOR TYPE 2 DIABETES MELLITUS PATIENTS WITH COMPLICATIONS TREATED AT CHIEM HOA GENERAL HOSPITAL IN 2023

Tran Thuy Linh1,2, Dinh Thi Thanh Hue3,4, Lam Thi Lan Anh1,2, Le Thi Thao Nguyen5,6, Nguyen Ngoc Hoai1,2, Dao Thi Linh1,2, Lam Thi Thanh Nga1,2, Dao Thu Thao1,2, Thai Van Trung1,2, Nguyen Van Hieu1,2, Do Thi Huyen7,8, Nguyen Duy Khanh1,2, Phan Huu Vinh1,2
1 School for Preventive Medicine and Public Health, Hanoi Medical University
2 Viện đào tạo Y học Dự phòng và Y tế Công cộng, Trường Đại học Y Hà Nội
3 Hanoi Medical University Hospital
4 Bệnh viện Đại học Y Hà Nội
5 Thanh Hoa Branch of Hanoi Medical University
6 Phân hiệu Thanh Hóa trường Đại học Y Hà Nội
7 Vinmec International General Hospital
8 Bệnh viện đa khoa quốc tế Vinmec
Corresponding author: phvinh2001@gmail.com
DOI: 10.52163/yhc.v65i6.1675
20 Views
22 Downloads
Keywords
Type 2 diabetes direct medical costs Chiem Hoa general hospital
Abstract

Objective: To describe certain characteristics of Type 2 Diabetes Mellitus (T2DM) patients with complications and analyze the direct medical treatment costs for these patients at Chiêm Hóa General Hospital in 2023.

Methods: This is a cross-sectional descriptive study using electronic medical records of 1953 T2DM patients with complications receiving outpatient treatment at the Endocrinology Department of Chiêm Hóa General Hospital in 2023.

Results: Among the study subjects, 52.64% were male and 47.36% were female, predominantly aged 60-70 years and above 70 years. Neurological complications (36.04%) and cardiovascular complications (31.54%) were the most common. Among the cost components, the average annual medication cost was the highest at 4,592,936 VND per year. The total expenditure for renal complications was the highest (9,175,619 ± 4,256,098 VND).

Conclusion: The study provides a comprehensive overview of the disease status and medical costs for the treatment of T2DM with complications in Vietnam, highlighting the significant dependence on medication and testing costs. It underscores the importance of blood glucose control, regular disease management, and minimizing risk factors to prevent severe complications.

References
[1]
Dall T, Mann SE, Zhang Y, Martin J, Chen Y, Hogan P. Economic Costs of Diabetes in the U.S. in 2007. Diabetes Care. 2008;31 (3):596-615. doi:10.2337/dc08-9017 Google Scholar
[2]
Internationl Diabetes Federation. Global diabetes data report 2000 — 2045. https://diabetesatlas.org/data/. Google Scholar
[3]
Seuring T, Archangelidi O, Suhrcke M. The Economic Costs of Type 2 Diabetes: A Global Systematic Review. Pharmacoeconomics. 2015;33 (8):811-831. doi:10.1007/s40273-015-0268-9 Google Scholar
[4]
Pham Huy Tuan Kiet, Kieu Thi Tuyet Mai, Duc Duong T, et al. Direct medical costs of diabetes and its complications in Vietnam: A national health insurance database study. Diabetes Res Clin Pract. 2020;162:108051. doi:10.1016/j.diabres.2020.108051 Google Scholar
[5]
Kautzky-Willer A, Leutner M, Harreiter J. Sex differences in type 2 diabetes. Diabetologia. 2023;66 (6):986-1002. doi:10.1007/s00125-023-05891-x Google Scholar
[6]
Domeikienė A, Vaivadaitė J, Ivanauskienė R, Padaiga Ž. Direct cost of patients with type 2 diabetes mellitus healthcare and its complications in Lithuania. Medicina. 2014;50 (1):54-60. doi:10.1016/j.medici.2014.05.007 Google Scholar
[7]
Standards of Medical Care in Diabetes—2020 Abridged for Primary Care Providers | Clinical Diabetes | American Diabetes Association. https://diabetesjournals.org/clinical/article/38/1/10/32237/. Accessed June 9, 2024. Google Scholar
[8]
William R, Van Gaal L, Lucioni C. Assessing the impact of complication on the costs of type II diabetes. 45:13-17. doi:10.1007/s00125-002-0859-9 Google Scholar
[9]
Cost of diabetes and its complications: results from a STEPS survey in Punjab, India | Global Health Research and Policy | Full Text. https://ghrp.biomedcentral.com/articles/10.1186/s41256-023-00293-3. Accessed June 9, 2024. Google Scholar
[10]
Han G, Spencer MS, Ahn S, et al. Group-based trajectory analysis identifies varying diabetes-related cost trajectories among type 2 diabetes patients in Texas: An empirical study using commercial insurance. BMC Health Services Research. 2023;23 (1):1116. doi:10.1186/s12913-023-10118-1 Google Scholar